These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 8907292)
1. Effect of kappa-casein split peptides on platelet aggregation and on thrombus formation in the guinea-pig. Bal dit Sollier C; Drouet L; Pignaud G; Chevallier C; Caen J; Fiat AM; Izquierdo C; Jolles P Thromb Res; 1996 Feb; 81(4):427-37. PubMed ID: 8907292 [TBL] [Abstract][Full Text] [Related]
3. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo. Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956 [TBL] [Abstract][Full Text] [Related]
4. The antithrombotic effect of aurin tricarboxylic acid in the guinea pig is not solely due to its interaction with the von Willebrand factor-GPIb axis. Azzam K; Cissé-Thiam M; Drouet L Thromb Haemost; 1996 Jan; 75(1):203-10. PubMed ID: 8713802 [TBL] [Abstract][Full Text] [Related]
5. Casein peptide release and passage to the blood in humans during digestion of milk or yogurt. Chabance B; Marteau P; Rambaud JC; Migliore-Samour D; Boynard M; Perrotin P; Guillet R; Jollès P; Fiat AM Biochimie; 1998 Feb; 80(2):155-65. PubMed ID: 9587673 [TBL] [Abstract][Full Text] [Related]
6. The antithrombotic effect of KRDS, a lactotransferrin peptide, compared with RGDS. Drouet L; Bal dit Sollier C; Cisse M; Pignaud G; Mazoyer E; Fiat AM; Jolles P; Caen JP Nouv Rev Fr Hematol (1978); 1990; 32(1):59-62. PubMed ID: 2349083 [TBL] [Abstract][Full Text] [Related]
7. Analogy between fibrinogen and casein. Effect of an undecapeptide isolated from kappa-casein on platelet function. Jollès P; Lévy-Toledano S; Fiat AM; Soria C; Gillessen D; Thomaidis A; Dunn FW; Caen JP Eur J Biochem; 1986 Jul; 158(2):379-82. PubMed ID: 3732274 [TBL] [Abstract][Full Text] [Related]
8. Antithrombotic effects of TAK-029, a novel GPIIb/IIIa antagonist, in guinea pigs: comparative studies with ticlopidine, clopidogrel, aspirin, prostaglandin E1 and argatroban. Kawamura M; Imura Y; Moriya N; Kita S; Fukushi H; Sugihara H; Nishikawa K; Terashita Z J Pharmacol Exp Ther; 1996 Apr; 277(1):502-10. PubMed ID: 8613960 [TBL] [Abstract][Full Text] [Related]
9. Trowaglerix Venom Polypeptides As a Novel Antithrombotic Agent by Targeting Immunoglobulin-Like Domains of Glycoprotein VI in Platelet. Chang CH; Chung CH; Tu YS; Tsai CC; Hsu CC; Peng HC; Tseng YJ; Huang TF Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1307-1314. PubMed ID: 28596377 [TBL] [Abstract][Full Text] [Related]
11. Antithrombotic effect of a recombinant von Willebrand factor, VCL, on nitrogen laser-induced thrombus formation in guinea pig mesenteric arteries. Azzam K; Garfinkel LI; Bal dit Sollier C; Cisse Thiam M; Drouet L Thromb Haemost; 1995 Feb; 73(2):318-23. PubMed ID: 7792749 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of arterial thrombosis and platelet function by nafazatrom. Buchanan MR; Blajchman M; Hirsh J Thromb Res; 1982 Oct; 28(2):157-70. PubMed ID: 6758186 [TBL] [Abstract][Full Text] [Related]
13. [Inhibition of thrombus formation by anti-Willebrand monoclonal antibodies in the guinea pig]. Cissé-Thiam M; Girma JP; Meyer D; Drouet L Dakar Med; 1999; 44(1):45-8. PubMed ID: 10797986 [TBL] [Abstract][Full Text] [Related]
14. Guinea pig blood: a model for the pharmacologic modulation of the GPIb/IX-vWF axis. André P; Hamaud P; Bal dit Sollier C; Drouet V; Garfinkel LI; Uzan A; Caen JP; Drouet LO Thromb Res; 1996 Jul; 83(2):127-36. PubMed ID: 8837311 [TBL] [Abstract][Full Text] [Related]
16. Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists. Cook NS; Zerwes HG; Tapparelli C; Powling M; Singh J; Metternich R; Hagenbach A Thromb Haemost; 1993 Sep; 70(3):531-9. PubMed ID: 8259560 [TBL] [Abstract][Full Text] [Related]
17. Inhibition effects of KRDS, a peptide derived from lactotransferrin, on platelet function and arterial thrombus formation in dogs. Wu G; Ruan C; Drouet L; Caen J Haemostasis; 1992; 22(1):1-6. PubMed ID: 1381697 [TBL] [Abstract][Full Text] [Related]
18. Hydrogen sulfide-releasing aspirin derivative ACS14 exerts strong antithrombotic effects in vitro and in vivo. Pircher J; Fochler F; Czermak T; Mannell H; Kraemer BF; Wörnle M; Sparatore A; Del Soldato P; Pohl U; Krötz F Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):2884-91. PubMed ID: 23023375 [TBL] [Abstract][Full Text] [Related]
19. Antithrombotic effects of the novel inhibitor of thrombin-induced offtelet aggregation and thrombus formation, 3-[2-[1,1':2',1"]-terphenyl-4'-yl)ethyl]phenoxyacetic acid. Miyamae T; Hashizume H; Ogawa T; Okayama T; Nukui E; Oshima K; Morikawa T; Hagiwara M Arzneimittelforschung; 1997 Jan; 47(1):13-8. PubMed ID: 9037437 [TBL] [Abstract][Full Text] [Related]
20. RGDV peptide selectively inhibits platelet-dependent thrombus formation in vivo. Studies using a baboon model. Cadroy Y; Houghten RA; Hanson SR J Clin Invest; 1989 Sep; 84(3):939-44. PubMed ID: 2760221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]